RESULTS AND DISCUSSION

Slides:



Advertisements
Similar presentations
Nicholas Johnson Rabies and Wildlife Zoonoses Group
Advertisements

Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Immune Responses to HIV
A RABIES CELL PHONE ADVISORY SYSTEM: A CULTURALLY TARGETED TOOL DESIGNED TO REDUCE HUMAN RABIES SUFFERING IN THE PHILIPPINES Introduction Rabies in the.
West Nile Virus Timeline  1937  First Case reported  1950  Virus studied in Egypt  1957  Outbreak in Israel  1960  Equine cases  1999  Appeared.
Encephalitis B virus. Biological properties Also called Japanese encephalitis virus (flavivirus ) +ssRNA Capsid: Icosahedral symmetry Enveloped Three.
CBER Perspective VRBPAC Meeting, November 16, 2010.
Terry Kotrla, MS, MT(ASCP)BB
BY CINDY RAMEY West Nile Virus. West Nile virus (WNV) is a mosquito-borne zoonotic arbovirus Family: Flaviviridae Genus: Flavivirus Japanese Encephalitis.
NEPAL IS ALSO KNOWN AS. The country of Mount Everest.
Cerebral Cysticercosis Zheng Dongming. In the central and south America and in parts of Africa and the Middle East,south-east Asia. This is the larval.
North Carolina STARI Introduction Barbara Johnson, PhD –CDC, Foothills Campus, 3150 Rampart Road, Fort Collins, CO –Phone:
RESULTS: The inactivated vaccine provided mild protection of the ferrets from the SARS-CoV.
DISEASE, RECOVERY AND DIAGNOSIS PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College,
Polio. Poliomyelitis, often called polio or infantile paralysis, is an acute viral infectious disease which is spread from person-to-person via the.
By Dr. Victoria J. Cabrera DVM.  Is a lethal encephalitis cause by a virus in the family Rhabdoviridae genus Lyssavirus  Exposure occurs through the.
Rabies Lecture 6 Dr. Paul Bartlett, MPH., DVM., Ph.D.
PUBH_224_Basic Medical Care in Primary Care Unit Topic Rabies Benjawan Nunthachai.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
MUMPS MUMPS.
Create a concept map of the adaptive immune system.
Continue reading Chapter 13 and Supp 14
Specimen Collection Guide for Cattle or Horses with Suspected Rabies, West Nile Virus Encephalitis or Bovine Spongiform Encephalopathy (BSE) Adapted from.
Martine Bruley Rosset UMR S 938 INSERM Hôpital St Antoine Paris France
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Avian Encephalomyelitis (AE) (Epidemic Tremors)
Immune Responses to HIV
RABIES.
Family Rhabdoviridae. Rabies virus.
Royal Thai Army Roles of mosquito vectors, bats, and swine in the epidemiology of emerging and re-emerging infectious diseases Akina Sukasem, 2LT Kanokporn.
Rabies.
Assessment of current virotherapeutic application schemes: “hit hard and early” versus “killing softly”?  Benjamin Ruf, Ulrich M Lauer  Molecular Therapy.
Dear Student, Welcome to the exciting & fascinating world of
A Framework of ethical decision making
Non-ARV Based Interventions to Combat HIV/AIDS: New Insights and Initiatives Yves Lévy Inserm, VRI.
A Framework of ethical decision making
Neoplastic Diseases.
Dr .Ghazi F.Haji Cardiologist AL-Kindy Medical collage
Yellow fever deepak b. saxena.
Spread, Treatment, and Prevention of Disease
Rabies virus and Prion Dongli Pan
Hepatitis Primary Care: Clinics in Office Practice
Cerebrospinal fluid.
EM R3 김현진.
Lecture 6 Dr. Paul Bartlett, MPH., DVM., Ph.D.
Cryptococcal Immune Reconstitution Inflammatory Syndrome
DEVELOPMENT OF A NOVEL VNT ASSAY USING QRT-PCR-BASED ENDPOINT ASSESSMENT FOR RAPID DETECTION AND TITRATION OF NEUTRALIZING ANTIBODIES AGAINST FMDV.
Vaccine Differentiation Group
A PRIME-BOOST VACCINATION STRATEGY IN CATTLE TO PREVENT SEROTYPE O FMDV INFECTION USING A “SINGLE-CYCLE” ALPHAVIRUS VECTOR AND EMPTY CAPSID PARTICLES Maria.
Chapter 3 - The Immune System
Antibodies and B Cell Memory in Viral Immunity
Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus Infection  Sharookh B. Kapadia, Beth Levine,
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing.
Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1  Richard Brans,
Cryptococcal Immune Reconstitution Inflammatory Syndrome
Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients—implications for treatment  L. Pettersson,
Rabies virus Member of the Lyssavirus of the Rhabdoviridae Dongli Pan
Volume 98, Issue 5, Pages (September 1999)
The pho4Δ mutant is less virulent than the WT strain in intranasal (A to C) and intravenous (D to F) models of cryptococcosis. The pho4Δ mutant is less.
Volume 30, Issue 2, Pages (February 2009)
Unit 4 - Immunology and Public Health
RUBEOLA OR MORBILLI Department of infectious disease WANG JINGYAN
Chapter 3 - The Immune System
SERMINER PRESENTATION BY TUESIMI CINDERELLA 15/SCI05/015 MEDICAL IMPORTANCE OF VIRUS RABISE.
Critical role for glycosphingolipids in Niemann-Pick disease type C
Volume 16, Issue 10, Pages (October 2008)
Immunologic and pharmacokinetic studies.
Clinical Scenario A 40 years old man presented in emergency with aggressive behaviour and froth coming from mouth. He could not give any history of his.
Volume 12, Issue 5, Pages (November 2005)
Presentation transcript:

RESULTS AND DISCUSSION Presence of Virus Neutralizing Antibodies in Cerebral Spinal Fluid Correlates with Non-Lethal Rabies in Dogs Clement W. Gnanaduraia*, Ming Zhou a*, Wenqi He a, Christina M. Leyson a, Chien-tsun Huang a, Deepak Kumar a, Gregory Salyards a,b, Stephen B Harvey b, Zhenhai Chen c, Biao He c, Yang Yang a,d, D. C. Hoopere, Berhnard Dietzcholde, and Zhen F. Fu a,d† Department of Pathology a, Population Health b, Infectious Diseases c, College of Veterinary Medicine, University of Georgia Athens, GA 30602, USA; State-key Laboratory of Agricultural Microbiology d, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China; Departments of Cancer Biology and Neurological Surgery e, Thomas Jefferson University, Philadelphia, PA 19107, USA. 3. Analysis of brain sections for histopathology and immunohistochemistry reveals, increased cell infiltrates and perivascular cuffing of mononuclear cells in the hippocampus, hypothalamus and cerebellum of dogs that succumbed to rabies. Only residual cell accumulation was observed in the recovered dogs while evidence of inflammation was absent in the immunized dogs. 4. Quantification of CD3-positive cells in different parts of the brains of the groups of animals indicates that significantly more CD3+ cells in the CNS of the dogs that succumbed to rabies than in those that survived. 5. Viral antigens G and N proteins were detected only the hippocampus, hypothalamus and cerebellum of the dogs that succumbed to rabies. No viral antigens were detected in the CNS of recovered or immunized dogs. ABSTRACT MATERIALS AND METHODS 1. Animals Dogs were experimentally infected with wild type rabies virus (RABV, DRV-Mexico) and an another group of dogs were immunized with a RABV vaccine then challenged with DRV suspension. 2. Observations Dogs were observed at least two to four times a day after challenge for rabies related clinical signs. 3. Sample collection Blood, CSF and brain samples were collected before infection and/or at the time of termination. 4. Analysis Complete blood counts (CBC), serum biochemistry, histopathology, immunohistochemistry, antibody titration, and CSF cytology. Rabies is traditionally considered a uniformly fatal disease after onset of clinical manifestations. However, increasing evidence indicates that non-lethal infection as well as recovery from flaccid paralysis and encephalitis occurs in laboratory animals as well as humans. Here, group of dogs were experimentally infected with wild type rabies virus (RABV, DRV-Mexico) and an another group of dogs were immunized with a RABV vaccine then challenged with DRV suspension by direct inoculation into the left hemisphere of the temporalis muscle. Dogs were observed at least two to four times a day after challenge for rabies related clinical signs. Blood, CSF and brain samples were collected before infection and/or at the time of termination for various analyses including complete blood counts (CBC), serum biochemistry, histopathology, immunohistochemistry, antibody titration, and CSF cytology. The results indicates, non-lethal rabies infection in dogs correlates with the presence of high level of virus neutralizing antibodies (VNA) in the cerebral spinal fluid (CSF) and mild immune cell accumulation in the central nervous system (CNS). By contrast, dogs that succumbed to rabies showed only little or no VNA in the serum or in the CSF and severe inflammation in the CNS. Dogs vaccinated with a rabies vaccine showed no clinical signs of rabies and survived challenge with a lethal dose of wild-type DRV. VNA was detected in the serum, but not in the CSF of immunized dogs. Thus the presence of VNA is critical for inhibiting virus spread within the CNS and eventually clearing the virus from the CNS. Therefore production of VNA within the CNS or invasion of VNA from the periphery into the CNS via compromised blood-brain barrier is important for clearing the virus infection from CNS; thereby preventing an otherwise lethal rabies virus infection. RESULTS AND DISCUSSION 1. Detection of VNA in the CSF shows high level of VNA in the CSF and also in serum of dogs that recovered from rabies, whereas dogs that succumbed to rabies showed only little or no VNA in the serum or in the CSF. 2. In the surviving dogs, total proteins and WBC counts in CSF were higher than those in the dogs prior to infection or in the immunized animals, but were much lower than those in the terminally ill animals. INTRODUCTION 1. Rabies is a highly lethal disease caused by the neurotropic rabies virus (RABV). It has been estimated that about 55,000 persons died from rabies each year mostly in Africa and Asia (WHO., 2005). 2. Successful vaccines have been developed for the prophylaxis of the disease. Timely post-exposure prophylaxis (PEP) can prevent the development of rabies, when individuals are exposed to the virus. 3. Unfortunately, the PEP treatment is ineffective once clinical signs have appeared. It is generally believed that virus clearance is impossible once the virus reaches the brain (Jackson et al., 2009). 4. However, there is now increasing evidence that non-lethal infection can occur in various animal species and in humans (CDC., 2012). 5. The clearance of rabies virus from the CNS requires the induction of innate immune responses in the CNS, induction of RABV-specific adaptive immunity in the periphery, as well as infiltration of immune effectors across the blood-brain barriers (BBB) (Phares et al., 2006). CONCLUSIONS 1. Non-lethal infection with wt RABV correlates with the presence of VNA in the CNS. 2. Presence of VNA within the CNS or invasion of VNA from the periphery into the CNS via compromised blood-brain barrier is important for clearing the virus infection from CNS.